FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") (FENC)
CUSIP: 31447P100
Q1 2018 13F Holders as of 31 Mar 2018
- Type / Class
- Equity / Common stock, no par value (the "Shares")
- Shares outstanding
- 34,145,841
- Total 13F shares
- 7,623,491
- Share change
- +401,692
- Total reported value
- $92,186,011
- Price per share
- $12.09
- Number of holders
- 21
- Value change
- +$4,858,661
- Number of buys
- 11
- Number of sells
- 6
Quarterly Holders Quick Answers
What is CUSIP 31447P100?
CUSIP 31447P100 identifies FENC - FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 31447P100:
Top shareholders of FENC - FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Southpoint Capital Advisors LP |
13F
|
Company |
12%
|
3,997,214
|
$40,052,000 | — | 31 Dec 2017 | |
| 683 Capital Management, LLC |
13F
|
Company |
2.5%
|
867,185
|
$8,689,000 | — | 31 Dec 2017 | |
| Opaleye Management Inc. |
13F
|
Company |
2.5%
|
846,900
|
$8,486,000 | — | 31 Dec 2017 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
2.2%
|
741,175
|
$7,390,000 | — | 31 Dec 2017 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
0.6%
|
206,000
|
$2,726,000 | — | 31 Dec 2017 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.73%
|
250,000
|
$2,505,000 | — | 31 Dec 2017 | |
| PUTNAM INVESTMENTS LLC |
13F
|
Company |
0.34%
|
117,645
|
$1,173,000 | — | 31 Dec 2017 | |
| Granahan Investment Management, LLC |
13F
|
Company |
0.17%
|
59,044
|
$592,000 | — | 31 Dec 2017 | |
| UNITED SERVICES AUTOMOBILE ASSOCIATION |
13F
|
Company |
0.15%
|
52,848
|
$527,000 | — | 31 Dec 2017 | |
| Cardinal Capital Management |
13F
|
Company |
0.04%
|
12,037
|
$120,000 | — | 31 Dec 2017 | |
| Hartford Financial Management Inc. |
13F
|
Company |
0.01%
|
2,150
|
$21,000 | — | 31 Dec 2017 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
1,091
|
$14,000 | — | 31 Dec 2017 | |
| UBS Group AG |
13F
|
Company |
0%
|
813
|
$8,000 | — | 31 Dec 2017 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0%
|
604
|
$6,000 | — | 31 Dec 2017 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
366
|
$4,000 | — | 31 Dec 2017 | |
| TORONTO DOMINION BANK |
13F
|
Company |
0%
|
57
|
$1,000 | — | 31 Dec 2017 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
4
|
$32 | — | 31 Dec 2017 |
Institutional Holders of FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") (FENC) as of Q1 2018
As of 31 Mar 2018,
FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") (FENC) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,623,491 shares.
The largest 10 holders included
Southpoint Capital Advisors LP, Opaleye Management Inc., 683 Capital Management, LLC, EVENTIDE ASSET MANAGEMENT, LLC, venBio Select Advisor LLC, PUTNAM INVESTMENTS LLC, ACUTA CAPITAL PARTNERS, LLC, MILLENNIUM MANAGEMENT LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and GRANAHAN INVESTMENT MANAGEMENT INC/MA.
This page lists
21
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2018 vs Q4 2017 Across Filers
Q4 2017 holders
16
Q1 2018 holders
21
Holder diff
5
| Investor | Q4 2017 Shares | Q1 2018 Shares | Share Diff | Share Chg % | Q4 2017 Value $ | Q1 2018 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.